Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRVI | Class A Common Stock | Award | $11.4K | +495 | +6.6% | $22.95 | 8K | Apr 30, 2021 | Direct | F1 |
transaction | MRVI | Class A Common Stock | Award | $12.4K | +542 | +6.78% | $22.95 | 8.54K | Oct 31, 2021 | Direct | F1 |
transaction | MRVI | Class A Common Stock | Award | +17K | +199.13% | 25.5K | Jan 25, 2022 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRVI | Employee Stock Option (Right to Buy) | Award | $0 | +31.5K | $0.00 | 31.5K | Jan 25, 2022 | Class A Common Stock | 31.5K | $26.32 | Direct | F3 |
Id | Content |
---|---|
F1 | The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,037 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). |
F2 | Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the Reporting Person's continued employment with the Issuer. |
F3 | Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer. |